Study of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS)

NCT04937907 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Alport Syndrome, X-Linked

Interventions

DRUG: Hydroxychloroquine Sulfate 100 milligram (mg) Tab
DRUG: Benazepril hydrochloride 10 milligram (mg) Tab

Sponsor

Shanghai Children's Hospital